I reported previously (see here) on Israel’s DreaMed Diabetes monitors. DreaMed has just partnered with French company BioCorp to create an Artificially Intelligent system that integrates BioCorp’s Mallya smart cap for pen injectors with DreaMed’s Advisor Pro insulin analysis system.
AI system for diabetes treatment
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.